Diagnostic Tests for Antiribosomal P Protein Antibodies: A Comparative Evaluation of Immunoblotting and ELISA Assays

We compared the clinical sensitivity and specificity of three different methods for the detection of serum antiribosomal P protein (anti-P) antibodies in systemic lupus erythematosus (SLE). Sera from 60 unselected SLE patients, 100 healthy subjects and 100 patients with other rheumatic inflammatory...

Full description

Saved in:
Bibliographic Details
Published in:Journal of autoimmunity 2002-08, Vol.19 (1-2), p.71-77
Main Authors: Ghirardello, Anna, Caponi, Laura, Franceschini, Franco, Zampieri, Sandra, Quinzanini, Marzia, Bendo, Raffaele, Bombardieri, Stefano, Gambari, Pier Franca, Doria, Andrea
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antibodies - analysis
Biological and medical sciences
Enzyme-Linked Immunosorbent Assay - methods
Female
Humans
Immunoblotting
Lupus Erythematosus, Systemic - immunology
Male
Medical sciences
Middle Aged
Protozoan Proteins
ribosomal P proteins, antibody, systemic lupus erythematosus, ELISA, immunoblotting, sensitivity, specificity
Ribosomal Proteins - immunology
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We compared the clinical sensitivity and specificity of three different methods for the detection of serum antiribosomal P protein (anti-P) antibodies in systemic lupus erythematosus (SLE). Sera from 60 unselected SLE patients, 100 healthy subjects and 100 patients with other rheumatic inflammatory diseases were screened for anti-P antibodies by immunoblotting (IB) on P proteins from Raji cells and by two ELISA assays, one using the C-terminal 22 aminoacid long synthetic peptide (C-22) of P proteins, the other using a multiple antigen peptide (MAP) carrying four copies of the C-terminal 13 aminoacid long P peptide. Anti-P antibodies were found in 20% lupus sera by IB, 16.7% by MAP ELISA and 11.7% by C-22 ELISA. The specificity for SLE diagnosis of the three tests in healthy subjects and other rheumatic diseases was: 100% by IB, 100% (vs healthy subjects) and 97% (vs rheumatic diseases) by C-22 ELISA, 100% by MAP ELISA. The agreement between methods was good; differences in concordance rates were restricted to weak positivities. We observed a high concordance in the results of IB and ELISA methods for anti-P antibody detection. IB on P proteins extracted from human lymphoid cells is more sensitive than both ELISAs; IB and MAP ELISA perform better than the C-22 ELISA in determining weakly positive sera.
ISSN:0896-8411
1095-9157
DOI:10.1006/jaut.2002.0595